We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
According to people familiar with the matter, GlaxoSmithKline has sent out an information memorandum with preliminary details about its Indian consumer healthcare business to potential suitors and is seeking bids for the unit by the middle of next month